Prostate cancer gene
US5945522A · kind A · utility
17Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1997 |
| Grant date | Aug 31, 1999 |
| Priority date | — |
| Expiry date | Dec 22, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to PG1, a gene associated with prostate cancer. The invention also relates to methods of determining whether an individual is at risk for developing prostate cancer at a later date or whether an individual suffers from prostate cancer as a result of a mutation in the PG1 gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.